InsidersTradesSigma
Track the MusclePharm Corp share price and the full directors' dealings record of the company, a listed equity based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Operating in the Health Care sector, MusclePharm Corp has recorded 6 reports. The latest transaction was reported on 31 March 2022 (Cession). Among the most active insiders: White Winston Select Asset Fund Series Fund MP-18, LLC. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
6 of 6 declarations
MusclePharm Corp es una empresa centrada en la nutrición deportiva, que ofrece una gama de productos como proteínas en polvo y suplementos. Cotiza en el NASDAQ bajo el ticker XNAS.